These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11881408)

  • 1. [Chronic renal insufficiency. VI: Progression prevention].
    García Cepeda JR; García Sixto M; Pérez Fontán M
    Nefrologia; 2001; 21 Suppl 5():32-5. PubMed ID: 11881408
    [No Abstract]   [Full Text] [Related]  

  • 2. The CARI guidelines. Prevention of progression of kidney disease: pre-dialysis education for patients with chronic kidney disease.
    Thomas MC;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S46-8. PubMed ID: 17316280
    [No Abstract]   [Full Text] [Related]  

  • 3. [How to delay progression of chronic renal failure?].
    Garaix F; Rousset Rouvière C; Cailliez M; Bruno D; Tsimaratos M
    Arch Pediatr; 2009 Jun; 16(6):703-5. PubMed ID: 19541137
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
    Maione A; Strippoli GF
    Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of chronic glomerulonephritis in the aspect of prevention of terminal renal insufficiency].
    Tareev EM
    Ter Arkh; 1976; 48(7):3-10. PubMed ID: 996744
    [No Abstract]   [Full Text] [Related]  

  • 6. The CARI guidelines. Prevention of progression of kidney disease: early detection of patients with kidney disease.
    Thomas MC;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S37-40. PubMed ID: 17316276
    [No Abstract]   [Full Text] [Related]  

  • 7. The CARI guidelines. Prevention of progression of kidney disease: regular and frequent follow-up of patients with pre-end-stage kidney disease.
    Thomas MC;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S44-5. PubMed ID: 17316279
    [No Abstract]   [Full Text] [Related]  

  • 8. The CARI guidelines. Prevention of progression of kidney disease: early referral of patients with pre-end-stage kidney disease.
    Thomas MC;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S41-3. PubMed ID: 17316278
    [No Abstract]   [Full Text] [Related]  

  • 9. [Can we influence the progression of chronic kidney disease?].
    Kuhlmann U; Hoyer J
    Urologe A; 2009 Jul; 48(7):793-803; quiz 804-5. PubMed ID: 19590915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention and screening of chronic renal failure].
    Bourel M; Ardaillou R
    Bull Acad Natl Med; 2004; 188(8):1455-68. PubMed ID: 15918671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardio-renal anemia syndrome.
    Iaina A; Silverberg DS; Wexler D; Iaina Nomy L
    Med Pregl; 2007; 60 Suppl 2():145-50. PubMed ID: 18928182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of progression of kidney disease - CARI guidelines.
    Johnson DW
    Aust Fam Physician; 2007 May; 36(5):353. PubMed ID: 17492072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halting the progression of renal disease: where we stand?
    Campbell RC; Remuzzi G
    Nefrologia; 2002; 22(4):303-5. PubMed ID: 12369119
    [No Abstract]   [Full Text] [Related]  

  • 17. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.
    Nagano N; Miyata S; Obana S; Kobayashi N; Fukushima N; Burke SK; Wada M
    Nephrol Dial Transplant; 2003 Oct; 18(10):2014-23. PubMed ID: 13679475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemic of chronic kidney disease in India -what can be done?
    Prabahar MR; Chandrasekaran V; Soundararajan P
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):847-53. PubMed ID: 18711313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slowing the progression of chronic renal insufficiency.
    Tonelli M; Gill J; Pandeya S; Bohm C; Levin A; Kiberd BA
    CMAJ; 2002 Apr; 166(7):906-7. PubMed ID: 11949987
    [No Abstract]   [Full Text] [Related]  

  • 20. Progression of chronic kidney disease: can it be prevented or arrested?
    Jaber BL; Madias NE
    Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.